Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy (Q40147066)

17 September 2017

title

Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy (English)

1 reference

17 September 2017

0 references

15

Yusuf A Hannun

1 reference

17 September 2017

Saeed Elojeimy

1

1 reference

17 September 2017

Xiang Liu

2

1 reference

17 September 2017

John C McKillop

3

1 reference

17 September 2017

Ahmed M El-Zawahry

4

1 reference

17 September 2017

David H Holman

5

1 reference

17 September 2017

Jonathan Y Cheng

6

1 reference

17 September 2017

William D Meacham

7

1 reference

17 September 2017

Ayman Em Mahdy

8

1 reference

17 September 2017

Antonio F Saad

9

1 reference

17 September 2017

Lorianne S Turner

10

1 reference

17 September 2017

Joseph Cheng

11

1 reference

17 September 2017

Terrence A Day

12

1 reference

17 September 2017

Jian-Yun Dong

13

1 reference

17 September 2017

Alicja Bielawska

14

1 reference

17 September 2017

James Scott Norris

16

1 reference

17 September 2017

publication date

10 April 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

15

1 reference

17 September 2017

issue

7

1 reference

17 September 2017

page(s)

1259-1263

1 reference

Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible?

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

FasL gene therapy: a new therapeutic modality for head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

Mechanisms of resistance to TRAIL-induced apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

Biologically active sphingolipids in cancer pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

A bioinformatic approach to the identification of candidate genes for the development of new cancer diagnostics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

Human acid ceramidase is overexpressed but not mutated in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

Caspase-dependent and -independent cell death of Jurkat human leukemia cells induced by novel synthetic ceramide analogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

Simultaneous quantitative analysis of ceramide and sphingosine in mouse blood by naphthalene-2,3-dicarboxyaldehyde derivatization after hydrolysis with ceramidase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

Modulation of ceramide metabolism enhances viral protein apoptin's cytotoxicity in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

Cooperative prosurvival activity by ERK and Akt in human alveolar macrophages is dependent on high levels of acid ceramidase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

PP2A regulates BCL-2 phosphorylation and proteasome-mediated degradation at the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

Protein phosphatase 2A enhances the proapoptotic function of Bax through dephosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

Downregulation of c-FLIP sensitizes DU145 prostate cancer cells to Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300167

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300167

1 reference

17 September 2017

1 reference